Clearmind Medicine (CMND) Short Interest Ratio & Short Volume → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free CMND Stock Alerts $1.18 +0.01 (+0.59%) (As of 05:36 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Clearmind Medicine Short Interest DataCurrent Short Volume178,800 sharesPrevious Short Volume92,700 sharesChange Vs. Previous Month+92.88%Dollar Volume Sold Short$205,620.00Short Interest Ratio / Days to Cover0.1Last Record DateMarch 31, 2024Outstanding Shares1,690,000 sharesFloat Size2,920,000 sharesShort Percent of Float6.12%Today's Trading Volume113,103 sharesAverage Trading Volume1,382,180 sharesToday's Volume Vs. Average8% Short Selling Clearmind Medicine ? Sign up to receive the latest short interest report for Clearmind Medicine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCMND Short Interest Over TimeCMND Days to Cover Over TimeCMND Percentage of Float Shorted Over Time Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> Clearmind Medicine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024178,800 shares $205,620.00 +92.9%6.1%0.1 $1.15 3/15/202492,700 shares $117,729.00 -59.8%3.2%0.1 $1.27 2/29/2024230,700 shares $355,278.00 +31.3%7.9%0.1 $1.54 2/15/2024175,700 shares $237,195.00 +20.0%6.0%0.1 $1.35 1/31/2024146,400 shares $209,352.00 -83.0%5.4%0.1 $1.43 1/15/2024862,800 shares $1.17 million +5,891.7%52.6%0.4 $1.36 Get the Latest News and Ratings for CMND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter. 12/31/202314,400 shares $40,464.00 -65.4%0.9%0 $2.81 12/15/202341,600 shares $116,064.00 -70.6%2.7%0 $2.79 11/30/2023141,400 shares $494,900.00 +50.4%26.4%0.1 $3.50 11/15/202394,000 shares $358,140.00 -70.8%0.7%0 $3.81 10/31/2023322,000 shares $39,251.80 -90.1%2.5%0.2 $0.12 10/15/20233,240,000 shares $579,960.00 +2,129.9%24.3%1.8 $0.18 9/30/2023145,300 shares $23,248.00 -69.0%1.1%0.3 $0.16 9/15/2023468,400 shares $84,077.80 +141.3%9.4%1.3 $0.18 8/31/2023194,100 shares $75,931.92 +106.3%3.9%0.8 $0.39 8/15/202394,100 shares $40,839.40 -6.2%1.9%0.4 $0.43 7/31/2023100,300 shares $44,132.00 +6.9%2.0%0.2 $0.44 7/15/202393,800 shares $41,975.50 -7.5%1.9%0.1 $0.45 6/30/2023101,400 shares $48,165.00 -31.3%2.0%0.1 $0.48 6/15/2023147,500 shares $80,387.50 -37.0%2.9%0.1 $0.55 5/31/2023234,000 shares $135,720.00 -4.4%4.6%0.1 $0.58 5/15/2023244,700 shares $148,532.90 No Change4.8%0.1 $0.61 CMND Short Interest - Frequently Asked Questions What is Clearmind Medicine's current short interest? Short interest is the volume of Clearmind Medicine shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 178,800 shares of CMND short. 6.12% of Clearmind Medicine's shares are currently sold short. Learn More on Clearmind Medicine's current short interest. What is a good short interest percentage for Clearmind Medicine? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.12% of Clearmind Medicine's floating shares are currently sold short. Is Clearmind Medicine's short interest increasing or decreasing? Clearmind Medicine saw a increase in short interest in March. As of March 31st, there was short interest totaling 178,800 shares, an increase of 92.9% from the previous total of 92,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Clearmind Medicine's float size? Clearmind Medicine currently has issued a total of 1,690,000 shares. Some of Clearmind Medicine's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Clearmind Medicine currently has a public float of 2,920,000 shares. How does Clearmind Medicine's short interest compare to its competitors? 6.12% of Clearmind Medicine's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Clearmind Medicine: Bio-Path Holdings, Inc. (8.97%), Salarius Pharmaceuticals, Inc. (6.72%), Notable Labs, Ltd. (0.05%), Lucy Scientific Discovery Inc. (2.95%), Cyclacel Pharmaceuticals, Inc. (2.03%), CNS Pharmaceuticals, Inc. (0.49%), Qualigen Therapeutics, Inc. (1.74%), InMed Pharmaceuticals Inc. (0.17%), Comera Life Sciences Holdings, Inc. (2.38%), Dermata Therapeutics, Inc. (1.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Clearmind Medicine stock? Short selling CMND is an investing strategy that aims to generate trading profit from Clearmind Medicine as its price is falling. CMND shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clearmind Medicine? A short squeeze for Clearmind Medicine occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMND, which in turn drives the price of the stock up even further. How often is Clearmind Medicine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMND, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Bio-Path Short Interest Data Salarius Pharmaceuticals Short Interest Data Notable Labs Short Interest Data Lucy Scientific Discovery Short Interest Data Cyclacel Pharmaceuticals Short Interest Data CNS Pharmaceuticals Short Interest Data Qualigen Therapeutics Short Interest Data InMed Pharmaceuticals Short Interest Data Comera Life Sciences Short Interest Data Dermata Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMND) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm Press